THE EFFECTIVENESS, IMMUNOGENICITY, AND SAFETY OF THE Escherichia coli BASED BIVALENT HUMAN PAPILLOMAVIRUS (TYPES 16 AND 18) VACCINE PREVENTING CERVICAL CANCER: A Systematic Review. JIMKI [Internet]. 2025 Apr. 30 [cited 2026 Jun. 13];11(3):21-37. Available from: https://jimki.bapin.or.id/main/article/view/795